YgfB increases β-lactam resistance in Pseudomonas aeruginosa by counteracting AlpA-mediated ampDh3 expression.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
10 03 2023
Historique:
received: 05 07 2022
accepted: 17 02 2023
entrez: 9 3 2023
pubmed: 10 3 2023
medline: 14 3 2023
Statut: epublish

Résumé

YgfB-mediated β-lactam resistance was recently identified in multi drug resistant Pseudomonas aeruginosa. We show that YgfB upregulates expression of the β-lactamase AmpC by repressing the function of the regulator of the programmed cell death pathway AlpA. In response to DNA damage, the antiterminator AlpA induces expression of the alpBCDE autolysis genes and of the peptidoglycan amidase AmpDh3. YgfB interacts with AlpA and represses the ampDh3 expression. Thus, YgfB indirectly prevents AmpDh3 from reducing the levels of cell wall-derived 1,6-anhydro-N-acetylmuramyl-peptides, required to induce the transcriptional activator AmpR in promoting the ampC expression and β-lactam resistance. Ciprofloxacin-mediated DNA damage induces AlpA-dependent production of AmpDh3 as previously shown, which should reduce β-lactam resistance. YgfB, however, counteracts the β-lactam enhancing activity of ciprofloxacin by repressing ampDh3 expression and lowering the benefits of this drug combination. Altogether, YgfB represents an additional player in the complex regulatory network of AmpC regulation.

Identifiants

pubmed: 36894667
doi: 10.1038/s42003-023-04609-4
pii: 10.1038/s42003-023-04609-4
pmc: PMC9998450
doi:

Substances chimiques

Ciprofloxacin 5E8K9I0O4U
beta-Lactams 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

254

Subventions

Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : BO 1527/4-1

Informations de copyright

© 2023. The Author(s).

Références

Front Microbiol. 2019 Feb 21;10:100
pubmed: 30846971
EMBO J. 1994 Oct 3;13(19):4684-94
pubmed: 7925310
PLoS Pathog. 2009 Mar;5(3):e1000353
pubmed: 19325877
J Am Chem Soc. 2013 Apr 3;135(13):4950-3
pubmed: 23510438
mSystems. 2019 Dec 3;4(6):
pubmed: 31796566
RNA Biol. 2011 Jan-Feb;8(1):11-3
pubmed: 21282983
Mol Microbiol. 2020 Jun;113(6):1240-1254
pubmed: 32068313
Appl Environ Microbiol. 2016 Oct 27;82(22):6715-6727
pubmed: 27613678
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8433-8
pubmed: 26100878
J Infect Dis. 1978 Feb;137(2):122-30
pubmed: 627734
J Infect Dis. 1986 Nov;154(5):792-800
pubmed: 3490520
Antimicrob Agents Chemother. 2006 May;50(5):1780-7
pubmed: 16641450
Genome Biol. 2014;15(12):550
pubmed: 25516281
Antimicrob Agents Chemother. 2010 Nov;54(11):4678-83
pubmed: 20713678
Nucleic Acids Res. 2022 Aug 12;50(14):8321-8330
pubmed: 35871295
Clin Microbiol Infect. 2007 Apr;13(4):413-8
pubmed: 17359326
Antimicrob Agents Chemother. 1995 Aug;39(8):1691-5
pubmed: 7486902
Mol Microbiol. 2022 Dec 28;:
pubmed: 36577706
Antimicrob Agents Chemother. 2008 Oct;52(10):3694-700
pubmed: 18644952
J Med Microbiol. 2009 Sep;58(Pt 9):1133-1148
pubmed: 19528173
Antimicrob Agents Chemother. 2020 Feb 21;64(3):
pubmed: 31818817
Nat Commun. 2021 Mar 17;12(1):1702
pubmed: 33731715
Microb Drug Resist. 2016 Sep;22(6):470-6
pubmed: 27326855
PLoS Pathog. 2016 Dec 15;12(12):e1006071
pubmed: 27977800
Antimicrob Agents Chemother. 2018 Oct 24;62(11):
pubmed: 30104278
Nucleic Acids Res. 2019 May 7;47(8):e47
pubmed: 30783653
Antimicrob Agents Chemother. 1996 Aug;40(8):1914-8
pubmed: 8843303
J Bacteriol. 1982 Nov;152(2):636-42
pubmed: 6813310
J Microbiol Methods. 2006 Mar;64(3):391-7
pubmed: 15987659
Antimicrob Agents Chemother. 1990 Mar;34(3):487-8
pubmed: 2110438
Mol Microbiol. 2020 Aug;114(2):308-321
pubmed: 32279364
Nat Protoc. 2006;1(1):153-61
pubmed: 17406227
Proteins. 2004 Dec 1;57(4):874-7
pubmed: 15317022
Nat Chem Biol. 2013 Aug;9(8):491-3
pubmed: 23831760
Antimicrob Agents Chemother. 1995 Jun;39(6):1361-4
pubmed: 7574531
Antimicrob Agents Chemother. 1990 Sep;34(9):1814-5
pubmed: 2126693
Int J Antimicrob Agents. 2008 Jul;32(1):33-9
pubmed: 18538547
Nat Methods. 2009 May;6(5):343-5
pubmed: 19363495
Curr Pharm Des. 1999 Nov;5(11):881-94
pubmed: 10539994
Cell. 1997 Mar 21;88(6):823-32
pubmed: 9118225
Antimicrob Agents Chemother. 2008 Nov;52(11):3922-7
pubmed: 18779353

Auteurs

Ole Eggers (O)

Institute for Medical Microbiology and Hygiene, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), Eberhard Karls University Tübingen, Tübingen, Germany.

Fabian A Renschler (FA)

Institute for Medical Microbiology and Hygiene, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), Eberhard Karls University Tübingen, Tübingen, Germany.
German Centre for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.

Lydia Anita Michalek (LA)

Institute for Medical Microbiology and Hygiene, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), Eberhard Karls University Tübingen, Tübingen, Germany.

Noelle Wackler (N)

Institute for Medical Microbiology and Hygiene, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), Eberhard Karls University Tübingen, Tübingen, Germany.

Elias Walter (E)

Institute for Medical Microbiology and Hygiene, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), Eberhard Karls University Tübingen, Tübingen, Germany.

Fabian Smollich (F)

Institute for Medical Microbiology and Hygiene, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), Eberhard Karls University Tübingen, Tübingen, Germany.

Kristina Klein (K)

Institute for Medical Microbiology and Hygiene, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), Eberhard Karls University Tübingen, Tübingen, Germany.

Michael S Sonnabend (MS)

Institute for Medical Microbiology and Hygiene, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), Eberhard Karls University Tübingen, Tübingen, Germany.
NGS Competence Center Tübingen (NCCT), Institute for Medical Microbiology and Hygiene, Eberhard Karls University Tübingen, Tübingen, Germany.

Valentin Egle (V)

Institute for Medical Microbiology and Hygiene, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), Eberhard Karls University Tübingen, Tübingen, Germany.
Cluster of Excellence "Controlling Microbes to Fight Infections", University of Tübingen, Tübingen, Germany.

Angel Angelov (A)

NGS Competence Center Tübingen (NCCT), Institute for Medical Microbiology and Hygiene, Eberhard Karls University Tübingen, Tübingen, Germany.

Christina Engesser (C)

NGS Competence Center Tübingen (NCCT), Institute for Medical Microbiology and Hygiene, Eberhard Karls University Tübingen, Tübingen, Germany.

Marina Borisova (M)

Cluster of Excellence "Controlling Microbes to Fight Infections", University of Tübingen, Tübingen, Germany.
Department of Biology, Organismic Interactions/Glycobiology, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), Eberhard Karls University Tübingen, Tübingen, Germany.

Christoph Mayer (C)

Cluster of Excellence "Controlling Microbes to Fight Infections", University of Tübingen, Tübingen, Germany.
Department of Biology, Organismic Interactions/Glycobiology, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), Eberhard Karls University Tübingen, Tübingen, Germany.

Monika Schütz (M)

Institute for Medical Microbiology and Hygiene, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), Eberhard Karls University Tübingen, Tübingen, Germany.
German Centre for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.

Erwin Bohn (E)

Institute for Medical Microbiology and Hygiene, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), Eberhard Karls University Tübingen, Tübingen, Germany. erwin.bohn@med.uni-tuebingen.de.
German Centre for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany. erwin.bohn@med.uni-tuebingen.de.
Cluster of Excellence "Controlling Microbes to Fight Infections", University of Tübingen, Tübingen, Germany. erwin.bohn@med.uni-tuebingen.de.

Articles similaires

H

Jiekai Sun, Xu Wang, Ye Gao et al.
1.00
Animals Anti-Bacterial Agents Hydrogen Sulfide Mice Pseudomonas aeruginosa

Aminoacid functionalised magnetite nanoparticles Fe

Spoială Angela, Motelica Ludmila, Ilie Cornelia-Ioana et al.
1.00
Magnetite Nanoparticles Tryptophan Biocompatible Materials Microbial Sensitivity Tests Humans
Humans Bronchiectasis Female Polyendocrinopathies, Autoimmune Middle Aged
Pseudomonas aeruginosa Fimbriae, Bacterial Fimbriae Proteins Cryoelectron Microscopy Electron Microscope Tomography

Classifications MeSH